Myasthenia Gravis

"Myasthenia Gravis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)

Descriptor ID	D009157
MeSH Number(s)	C10.114.656 C10.668.758.725 C20.111.258.500
Concept/Terms	Myasthenia Gravis Myasthenia Gravis Myasthenia Gravis, Ocular Myasthenia Gravis, Ocular Ocular Myasthenia Gravis Myasthenia Gravis, Generalized Myasthenia Gravis, Generalized Generalized Myasthenia Gravis

Below are MeSH descriptors whose meaning is more general than "Myasthenia Gravis".

Diseases [C]
Nervous System Diseases [C10]
Autoimmune Diseases of the Nervous System [C10.114]
Myasthenia Gravis [C10.114.656]
Neuromuscular Diseases [C10.668]
Neuromuscular Junction Diseases [C10.668.758]
Myasthenia Gravis [C10.668.758.725]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Autoimmune Diseases of the Nervous System [C20.111.258]
Myasthenia Gravis [C20.111.258.500]

Below are MeSH descriptors whose meaning is related to "Myasthenia Gravis".

Below are MeSH descriptors whose meaning is more specific than "Myasthenia Gravis".

Myasthenia Gravis
Myasthenia Gravis, Autoimmune, Experimental
Myasthenia Gravis, Neonatal

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Myasthenia Gravis" by people in this website by year, and whether "Myasthenia Gravis" was a major or minor topic of these publications.

Bar chart showing 15 publications over 12 distinct years, with a maximum of 2 publications in 1997 and 2006 and 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	1	2
1999	1	0	1
2005	1	0	1
2006	1	1	2
2007	1	0	1
2010	2	0	2
2014	0	1	1
2015	1	0	1
2017	1	0	1
2019	1	0	1
2020	1	0	1
2021	1	0	1

Below are the most recent publications written about "Myasthenia Gravis" by people in Profiles.

Guidon AC, Muppidi S, Nowak RJ, Guptill JT, Hehir MK, Ruzhansky K, Burton LB, Post D, Cutter G, Conwit R, Mejia NI, Kaminski HJ, Howard JF. Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE). Muscle Nerve. 2021 09; 64(3):270-276.

View in: PubMed
Hamedani AG, Pistilli M, Singhal S, Shindler KS, Avery RA, Tamhankar MA, Liu GT. Outcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting. J Neuroophthalmol. 2020 03; 40(1):8-14.

View in: PubMed
Clifford KM, Hobson-Webb LD, Benatar M, Burns TM, Barnett C, Silvestri NJ, Howard JF, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, Laboy SM, Fellman MA, Howard DB, Kolb NA, Greene SM, Pasnoor M, Dimachkie MM, Barohn RJ, Hehir MK. Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. Muscle Nerve. 2019 04; 59(4):404-410.

View in: PubMed
Hehir MK, Hobson-Webb LD, Benatar M, Barnett C, Silvestri NJ, Howard JF, Howard D, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, LaBoy SM, Fellman MA, Greene SM, Pasnoor M, Burns TM. Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review. Neurology. 2017 Sep 05; 89(10):1069-1077.

View in: PubMed
Bryson EO, Manning E, Aloysi AS, Kellner CH. Successful electroconvulsive therapy in a patient with myasthenia gravis. J ECT. 2015 Mar; 31(1):e17-8.

View in: PubMed
Park DB, Dobson JV, Losek JD. All that wheezes is not asthma: cognitive bias in pediatric emergency medical decision making. Pediatr Emerg Care. 2014 Feb; 30(2):104-7.

View in: PubMed
Pineles SL, Avery RA, Moss HE, Finkel R, Blinman T, Kaiser L, Liu GT. Visual and systemic outcomes in pediatric ocular myasthenia gravis. Am J Ophthalmol. 2010 Oct; 150(4):453-459.e3.

View in: PubMed
Maddison P, McConville J, Farrugia ME, Davies N, Rose M, Norwood F, Jungbluth H, Robb S, Hilton-Jones D. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 2011 Jun; 82(6):671-3.

View in: PubMed
Chavis PS, Stickler DE, Walker A. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis. Arch Neurol. 2007 Dec; 64(12):1792-4.

View in: PubMed
Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006 Dec; 142(6):1026-35.

View in: PubMed

People

Explore

Similar Concepts

Top Journals